ParaReg - A web-based registry for lifelong monitoring of people with spinal cord injury

ParaReg - A web-based registry for lifelong monitoring of people with spinal cord injury - ParaReg

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00026026

Enrollment

30000

Registered

2021-08-04

Start date

2021-07-31

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G82

Interventions

Group 1: Data which is routinely collected during each inpatient stay in a DMGP-associated spinal cord injury (SCI) center routinely collected data on the socio-medical (e.g. main and secondary diagno

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: traumatic or non-traumatic spinal cord injury; age = 18

Exclusion criteria

Exclusion criteria: Cognitive limitations such as demetia which impact the validity of examination results (e.g. ISNCSCI)

Design outcomes

Primary

Measure	Time frame
H1: Comparison of frequency of rehospitalizations of the three groups with different initial treatment pathways ("primary rehabilitation in BG center," "primary rehabilitation in non-BG center with subsequent neurorehabilitation," and "primary rehabilitation in neurorehabilitation center"). H2: Correlation of length of primary treatment in days with frequency of rehospitalizations in the 1-2-year period. H3: Patient-related ratio of non-complication-related to complication-related rehospitalizations in the 1-2-year period. H4: Comparison of functional scores (SCIM III) stratified by lesion severity (AIS A-D), lesion level ranges (C1-C3, C4, C5, C6-T1, T2-T8, T9-T12, L1-S4/5), and age groups (18-30, 31-45, 46-60, 61-75, 75+) for Germany and North America (Model Spinal Injury System - USA, Rick Hansen Institute Registry - Canada).	—

Measure

Time frame

H1: Comparison of frequency of rehospitalizations of the three groups with different initial treatment pathways ("primary rehabilitation in BG center," "primary rehabilitation in non-BG center with subsequent neurorehabilitation," and "primary rehabilitation in neurorehabilitation center"). H2: Correlation of length of primary treatment in days with frequency of rehospitalizations in the 1-2-year period. H3: Patient-related ratio of non-complication-related to complication-related rehospitalizations in the 1-2-year period. H4: Comparison of functional scores (SCIM III) stratified by lesion severity (AIS A-D), lesion level ranges (C1-C3, C4, C5, C6-T1, T2-T8, T9-T12, L1-S4/5), and age groups (18-30, 31-45, 46-60, 61-75, 75+) for Germany and North America (Model Spinal Injury System - USA, Rick Hansen Institute Registry - Canada).

—

Secondary

Measure	Time frame
N1: SCIM III stratified by lesion severity (AIS), lesion level ranges, and age groups. N2: Comparison of post-discharge care status of age groups, severity (AIS) and lesion level ranges. N3: Correlation of age at time of death as a function of lesion level range, lesion severity (AIS), and payer. N4: Group comparison of frequency of readmissions for care settings "nursing home", "ambulatory care service", "non-professional care", "24-hour intensive care" in 1-2-year period. N5: Gender-specific number of rehospitalizations in the 1-2-year period.	—

Measure

Time frame

N1: SCIM III stratified by lesion severity (AIS), lesion level ranges, and age groups. N2: Comparison of post-discharge care status of age groups, severity (AIS) and lesion level ranges. N3: Correlation of age at time of death as a function of lesion level range, lesion severity (AIS), and payer. N4: Group comparison of frequency of readmissions for care settings "nursing home", "ambulatory care service", "non-professional care", "24-hour intensive care" in 1-2-year period. N5: Gender-specific number of rehospitalizations in the 1-2-year period.

—

Countries

Germany

Contacts

Public ContactRüdiger Rupp

Universitätsklinikum Heidelberg - Klinik für Paraplegiologie, Sektion Expermimentelle Neurorehabilitation

ruediger.rupp@med.uni-heidelberg.de-49(0)6221/562-9230

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026